Literature DB >> 7560287

Distribution of Big tau in the central nervous system of the adult and developing rat.

L J Boyne1, A Tessler, M Murray, I Fischer.   

Abstract

The diversity of neuronal morphology and function is correlated with specific expression of various microtubule associated proteins (MAPs). One of the major neuronal MAPs, tau, has multiple isoforms formed as a result of alternative splicing and phosphorylation that are differentially expressed during development. Big tau is a high molecular weight isoform that contains an additional large exon (4a) and is expressed primarily by neurons in the peripheral nervous system (PNS). We cloned the complete 4a exon in an expression vector, isolated the recombinant protein and produced antibodies specific to Big tau that were used to localize Big tau in the developing spinal cord and in the adult central nervous system (CNS). In developing spinal cord, Big tau is first expressed in the central projections of the dorsal root ganglia neurons and in motor neurons at embryonic day 18 and postnatal day 2, respectively. In the adult rat CNS, almost all neurons that extend processes into the PNS express Big tau, including all cranial nerve motor nuclei and central processes of most sensory ganglia; of these ganglia, only the bipolar neurons of the olfactory, vestibular and spiral ganglia did not express Big tau. Retinal ganglion cells are the only CNS neurons, whose processes remain entirely within the CNS, that express high levels of Big tau. The limited and specific distribution of Big tau is consistent with a role in stabilizing microtubules in axons that are subjected to great shear forces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560287     DOI: 10.1002/cne.903580209

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  23 in total

1.  Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells.

Authors:  P K Davis; G V Johnson
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration.

Authors:  J Nunez; I Fischer
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

4.  RNA protein granules modulate tau isoform expression and induce neuronal sprouting.

Authors:  Katharina Moschner; Frederik Sündermann; Heiko Meyer; Abel Pereira da Graca; Neele Appel; Achim Paululat; Lidia Bakota; Roland Brandt
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

5.  The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Authors:  Brittany N Dugger; Charisse M Whiteside; Chera L Maarouf; Douglas G Walker; Thomas G Beach; Lucia I Sue; Angelica Garcia; Travis Dunckley; Bessie Meechoovet; Eric M Reiman; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

Authors:  Zhicheng Chen; David Mengel; Ashvini Keshavan; Robert A Rissman; Andrew Billinton; Michael Perkinton; Jennifer Percival-Alwyn; Aaron Schultz; Michael Properzi; Keith Johnson; Dennis J Selkoe; Reisa A Sperling; Purvish Patel; Henrik Zetterberg; Douglas Galasko; Jonathan M Schott; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2018-11-09       Impact factor: 21.566

7.  Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.

Authors:  Jason G Weinger; Peter Davies; Christopher M Acker; Celia F Brosnan; Vladislav Tsiperson; Ashrei Bayewitz; Bridget Shafit-Zagardo
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

8.  Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.

Authors:  Mirta Boban; Mirjana Babić Leko; Terezija Miškić; Patrick R Hof; Goran Šimić
Journal:  J Neurosci Methods       Date:  2018-09-29       Impact factor: 2.390

Review 9.  Cytoskeletal pathologies of Alzheimer disease.

Authors:  James R Bamburg; George S Bloom
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

10.  Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.

Authors:  Marius Chiasseu; Jorge L Cueva Vargas; Laurie Destroismaisons; Christine Vande Velde; Nicole Leclerc; Adriana Di Polo
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.